Lipid Lowering Effect of Anti Diabetic Agents-Recent Research

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Pharma Research & Review

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sesame oil as a potential therapeutic agent against nutritional steatohepatitis

  2014cited by this paper
• Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver.

  2014cited by this paper
• Comparative evaluation of effects of combined oral anti-diabetic drugs (sulfonylurea plus pioglitazone and sulfonylurea plus metformin) over lipid parameters in type 2 diabetic patients -

  2013cited by this paper
• Olive and Sesame Oil Effect on Lipid Profile in Hypercholesterolemic Patients, Which Better?

  2013cited by this paper
• Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy

  2013cited by this paper
• Effects of nateglinide and acarbose on glycemic excursions in standardized carbohydrate and mixed-meal tests in drug-naïve type 2 diabetic patients.

  2013cited by this paper
• To study the antihyperglycaemic and lipid lowering effect of garlic as an adjunct to metformin in patients of type 2 diabetes mellitus with obesity

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes

  2012cited by this paper
• Metformin : Beyond Glycemic Control

  2012cited by this paper
• Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

  2011cited by this paper
• DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis

  2011cited by this paper
• COMPARATIVE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE ON LIPID PROFILE IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS Research Article

  2011cited by this paper
• Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

  2011cited by this paper
• Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))

  2010cited by this paper
• Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.

  2010cited by this paper
• Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.

  2010cited by this paper
• The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

  2010cited by this paper
• Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

  2010cited by this paper
• Effects of Pioglitazone and Metformin Fixed‐Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes

  2010cited by this paper
• Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

  2009cited by this paper
• Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus.

  2009cited by this paper
• Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control

  2009cited by this paper
• Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

  2009cited by this paper
• Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

  2008cited by this paper
• Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials

  2008cited by this paper
• Cardiovascular Diabetology BioMed Central Review

  2008cited by this paper
• Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

  2008cited by this paper
• Protection against hydrogen peroxide induced oxidative damage in rat erythrocytes by Mangifera indica L. peel extract.

  2008cited by this paper
• Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal

  2008cited by this paper
• Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

  2007cited by this paper
• Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

  2007cited by this paper
• Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

  2007cited by this paper
• The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes

  2007cited by this paper
• Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin.

  2006cited by this paper
• Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

  2006cited by this paper
• Diabetes and obesity: the twin epidemics

  2006cited by this paper
• Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

  2005cited by this paper
• Nutrient Content of Complementary Foods Based on Processed and Fermented Sorghum, Groundnut, Spinach, and Mango

  2005cited by this paper
• Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils.

  2005cited by this paper
• Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats.

  2005cited by this paper
• The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

  2004cited by this paper
• Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.

  2004cited by this paper
• Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes.

  2004cited by this paper
• Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.

  2003cited by this paper
• The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

  2002cited by this paper
• Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.

  2002cited by this paper
• Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

  2002influential reference
• Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review

  2001cited by this paper
• The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.

  2001cited by this paper
• Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.

  2000cited by this paper
• Repaglinide versus glyburide: a one-year comparison trial.

  1999cited by this paper
• The evolving role of a-glucosidase inhibitors

  1998cited by this paper
• The evolving role of alpha-glucosidase inhibitors.

  1998cited by this paper
• The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic Control

  1998cited by this paper
• Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes

  1998cited by this paper
• Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

  1995cited by this paper
• Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women

  1993cited by this paper
• New saponins from Mangifera indica.

  1993cited by this paper
• Sulfonylureas in NIDDM

  1992cited by this paper
• Effect of Acarbose on Carbohydrate and Lipid Metabolism in NIDDM Patients Poorly Controlled by Sulfonylureas

  1990cited by this paper
• Cellular Mechanism of Action of Metformin

  1990cited by this paper
• Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men.

  1989cited by this paper
• Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes

  1989cited by this paper
• Efficacy & Safety of Repaglinide as Monotherapy or with Metformin in Achieving the Recommended Glycemic Targets of Type 2

  year unknowncited by this paper

• Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment

  2024cites this paper
• Serum biochemical evaluation following administration of imidazolyl thiazolidinedione in streptozotocin-induced diabetic rats

  2024cites this paper
• Prescribing trends of antidiabetic drugs in diabetic and hypertensive diabetic patients in an urban tertiary care hospital of Bangladesh

  2017influential citation
• A CROOS SECTIONAL STUDY IN NORTH EASTERN UTTAR PRADESH POPULATION FOR THE ESTIMATION OF HDL, TRIGLYCERIDES LEVELS IN RECENTLY DIAGNOSED PATIENTS WITH DIABETES MELLITUS TYPE 2 TAKING METFORMIN ALONE, METFORMIN WITH ADD ON SITAGLIPTIN AND SITAGLIPTIN ALONE

  2017cites this paper